Viatris Launches First Generic Iron Sucrose Injection in the U.S.: A Game Changer for Anemia Management Viatris has received FDA approval for the first generic Iron Sucrose Injection, enhancing treatment options for patients with chronic kidney disease and iron deficiency anemia.

Viatris Launches First Generic Iron Sucrose Injection in the U.S.: A Game Changer for Anemia Management #United_States #Pittsburgh #kidney_disease #Viatris #Iron_Sucrose